Kirkland & Ellis LLP
05/29/2026 | Press release | Distributed by Public on 05/29/2026 10:24
Kirkland Advises AmbioPharm on Merger with CordenPharma
Kirkland & Ellis is advising Carlyle-sponsored AmbioPharm, a U.S.-headquartered peptide API contract development and manufacturing organization (CDMO) with facilities in North Augusta, South Carolina and Shanghai, on its merger with Astorg-owned CordenPharma, a leading global CDMO.
Read AmbioPharm's press release
The Kirkland team included corporate lawyers Laura Steinke, Gregory Scott, David Higgins, Jiayi Wang, Armand Della Monica, Jesse Sheley, Marissa Leonce, Chris Connolly, Luke Forryan and Yuefei Zhou; debt finance lawyers Sam Sherwood, Natasha Smith and Aman Nath; and tax lawyers Adam Kool and Patrick Nolan.
Kirkland & Ellis LLP published this content on May 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 29, 2026 at 16:24 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]